samedan logo
 
 
spacer
home > epc > winter 2003 > clinical trial recruitment and retention: the challenge of creative communications
PUBLICATIONS
European Pharmaceutical Contractor

Clinical Trial Recruitment and Retention: The Challenge of Creative Communications

As the UK pop groups 'Fun Boy Three' and 'Bananarama' sang in 1982: "It ain't what you do, it's the way that you do it, and that's what gets results". Speedy and appropriate patient recruitment and retention will get you results. To achieve speed and appropriateness, you need to communicate at all levels in a way that has meaning for your target audience. And in lay-land, you have probably only got one shot at getting this right.

Careful Pre-Planning and Questioning

Whether you are motivating your CROs, encouraging investigators, communicating with patients or navigating a narrow path through ethics committees, you need to constantly review what you are saying, to whom and why. Do any of these questions relate to you?

What is my recruitment message?
Who are my audience?
How does my audience like to receive information?
What are the best routes to dissemination of my message?
How can I motivate patients to comply?
How can I support investigators?
How can I pre-empt any retention difficulties and address them early?
How can I ensure that best practice in one site is properly disseminated to others worldwide?

It is also worth asking 'how much time have I got'? And crucially, 'what or where's my budget'? Followed by 'who can I get in to help me with all this'?


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Emma Sergeant, Managing Director, and Alison Eden, Creative Director at Fast4wD

Emma Sergeant is Managing Director of Fast4wD, the specialist clinical trial patient recruitment and retention arm of The Shire Health Group. She trained as a nurse in both adult and paediatric medicine and has 17 years' experience in health care. Emma has had pharmaceutical industry roles in sales, post-market surveillance, market development, media relations, corporate communications and brand management for product launch and generic protection. Emma was the Director of Communications at National Asthma & Respiratory Training Centre, worked with the WHO and was advisor to the UK Government on lung cancer.

Creative Director for Fast4wD, Alison Eden directs the creative content of clinical trial recruitment and retention campaigns. Alison is a writer and editor with over 15 years' experience in specialist medical publishing and PR. She has also worked as a journalist, most recently for FDC Reports Inc on The Pink Sheet. She has an English Language and Literature degree from St Anne's College, Oxford.

spacer
Emma Sergeant
spacer
spacer
spacer
Alison Eden
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

MipTec, October 14 – 16, 2008, Switzerland

MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com    
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement